{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:02:54Z","timestamp":1785294174544,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32ES011564"],"award-info":[{"award-number":["T32ES011564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL103455"],"award-info":[{"award-number":["P01HL103455"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132550"],"award-info":[{"award-number":["R01HL132550"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01DK096042"],"award-info":[{"award-number":["K01DK096042"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50AA024337"],"award-info":[{"award-number":["P50AA024337"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AA021978"],"award-info":[{"award-number":["R01AA021978"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL64937"],"award-info":[{"award-number":["R01HL64937"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK120531"],"award-info":[{"award-number":["P30DK120531"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","award":["T32ES011564"],"award-info":[{"award-number":["T32ES011564"]}],"id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jnutbio.2020.108399","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T21:39:11Z","timestamp":1586381951000},"page":"108399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane"],"prefix":"10.1016","volume":"81","author":[{"given":"Robin H.","family":"Isaacson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane I.","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas KH","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Freyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin E.","family":"Arteel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnutbio.2020.108399_bb0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.biopsych.2005.04.034","article-title":"The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)","volume":"58","author":"Kessler","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0010","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4088\/JCP.15m10278","article-title":"The economic burden of schizophrenia in the United States in 2013","volume":"77","author":"Cloutier","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0015","doi-asserted-by":"crossref","unstructured":"Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 national and state costs of excessive alcohol consumption. Am J Prev Med 2015;49:e73-e9.","DOI":"10.1016\/j.amepre.2015.05.031"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0020","first-page":"S1","article-title":"Summary of the comparative effectiveness review on off-label use of atypical antipsychotics","volume":"18","author":"Maher","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2082","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995-2008","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0030","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999-2004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0035","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.ATV.0000189155.75833.c7","article-title":"Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute","volume":"25","author":"Grundy","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0040","doi-asserted-by":"crossref","DOI":"10.5888\/pcd14.160287","article-title":"Metabolic syndrome prevalence by race\/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012","volume":"14","author":"Moore","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2008.09.025","article-title":"Weight effects associated with antipsychotics: a comprehensive database analysis","volume":"110","author":"Parsons","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0050","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.amepre.2008.11.020","article-title":"Obesity among those with mental disorders: a National Institute of Mental Health meeting report","volume":"36","author":"Allison","year":"2009","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0060","first-page":"A42","article-title":"Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states","volume":"3","author":"Colton","year":"2006","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0065","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1176\/appi.ajp.2013.12010127","article-title":"Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder","volume":"170","author":"Jarskog","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/JCP.0000000000000469","article-title":"A naturalistic randomized placebo-controlled trial of extended-release metformin to prevent weight gain associated with olanzapine in a US Community-dwelling population","volume":"36","author":"Rado","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v64n0513","article-title":"Metabolic syndrome in patients with schizophrenia","volume":"64","author":"Heiskanen","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/jpet.113.207621","article-title":"Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs","volume":"347","author":"Schmidt","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0085","doi-asserted-by":"crossref","first-page":"8267234","DOI":"10.1155\/2019\/8267234","article-title":"Biomarkers of oxidative stress in metabolic syndrome and associated diseases","volume":"2019","author":"Vona","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.taap.2010.01.011","article-title":"The rise of antioxidant signaling--the evolution and hormetic actions of Nrf2","volume":"244","author":"Maher","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0095","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neulet.2010.05.088","article-title":"Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics","volume":"479","author":"Padurariu","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/JCP.0b013e31819a6aa2","article-title":"Comparing the effects of high-dose vitamin E with those of placebo on insulin resistance in patients with schizophrenia treated with olanzapine","volume":"29","author":"Salmasi","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"ERr","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2007.11.078","article-title":"Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution","volume":"585","author":"van der Zwaal","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2005.11.050","article-title":"Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL\/6J mice and C57BL\/6J\/Nrf2 (\u2212\/\u2212) mice","volume":"243","author":"Hu","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0125","doi-asserted-by":"crossref","first-page":"E1323","DOI":"10.1152\/ajpendo.90617.2008","article-title":"Evaluating the glucose tolerance test in mice","volume":"295","author":"Andrikopoulos","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0130","first-page":"191","article-title":"The estimation of glycogen with the anthrone reagent","volume":"25","author":"Seifter","year":"1950","journal-title":"Arch Biochem"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0135","doi-asserted-by":"crossref","first-page":"G1227","DOI":"10.1152\/ajpgi.00050.2008","article-title":"Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice","volume":"294","author":"von Montfort","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0140","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1053\/j.gastro.2006.03.020","article-title":"Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1","volume":"130","author":"Bergheim","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0145","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.510250422","article-title":"Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo","volume":"25","author":"Arteel","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0150","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1053\/j.gastro.2003.08.030","article-title":"Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice","volume":"125","author":"McKim","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0155","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.abb.2008.11.004","article-title":"PKCepsilon plays a causal role in acute ethanol-induced steatosis","volume":"482","author":"Kaiser","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0165","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.taap.2011.09.019","article-title":"Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice","volume":"257","author":"Tan","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2006.12.008","article-title":"Tryptophan breakdown pathway in bipolar mania","volume":"102","author":"Myint","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0175","doi-asserted-by":"crossref","first-page":"G1211","DOI":"10.1152\/ajpgi.00322.2010","article-title":"Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism","volume":"299","author":"Huang","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0180","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jprot.2010.03.018","article-title":"Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver","volume":"73","author":"Kitteringham","year":"2010","journal-title":"J Proteomics"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/jpet.103.064261","article-title":"In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat","volume":"310","author":"Hu","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0190","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2174\/138920008785821675","article-title":"Interaction of the isothiocyanate sulforaphane with drug disposition and metabolism: pharmacological and toxicological implications","volume":"9","author":"Fimognari","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/schbul\/sbq053","article-title":"Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents","volume":"38","author":"Albaugh","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0200","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0278-6915(99)00082-4","article-title":"Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes","volume":"37","author":"Fahey","year":"1999","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2018.10.037","article-title":"Effect of ethanol on lipid metabolism","volume":"70","author":"You","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0210","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1073\/pnas.94.6.2557","article-title":"Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis","volume":"94","author":"Yang","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0215","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/apt.14952","article-title":"Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view","volume":"48","author":"Bessone","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.psyneuen.2017.12.004","article-title":"Obesity exacerbates the acute metabolic side effects of olanzapine","volume":"88","author":"Townsend","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00004850-200505000-00009","article-title":"Naturalistic observation on the hepatic enzyme changes in patients treated with either risperidone or olanzapine alone","volume":"20","author":"Pae","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.jnutbio.2020.108399_bb0230","first-page":"S46","article-title":"Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics","volume":"37","author":"Bender","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2016.09.009","article-title":"Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes","volume":"254","author":"Afarideh","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0240","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0245","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2014.01.009","article-title":"Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension","volume":"60","author":"Sung","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0250","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0255","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jnutbio.2020.108399_bb0260","first-page":"S51","article-title":"Therapy of NAFLD: antioxidants and cytoprotective agents","volume":"40","author":"Chang","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0265","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/01.mog.0000182863.96421.47","article-title":"Role of inflammation in nonalcoholic steatohepatitis","volume":"21","author":"Choi","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.jnutbio.2020.108399_bb0270","first-page":"S17","article-title":"Pathophysiology of nonalcoholic steatohepatitis","volume":"40","author":"McCullough","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0275","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0280","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00535-012-0552-9","article-title":"Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis","volume":"47","author":"Okada","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.etap.2018.12.008","article-title":"Comparison of the effects of sulforaphane and pioglitazone on insulin resistance and associated dyslipidemia, hepatosteatosis, and endothelial dysfunction in fructose-fed rats","volume":"66","author":"Shawky","year":"2019","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic Steatohepatitis and Prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jnutbio.2020.108399_bb0295","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.pnpbp.2007.05.005","article-title":"A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study","volume":"31","author":"Atasoy","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286319312422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286319312422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:34:16Z","timestamp":1777595656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955286319312422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":59,"alternative-id":["S0955286319312422"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108399","relation":{},"ISSN":["0955-2863"],"issn-type":[{"value":"0955-2863","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108399"}}